| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 90791 |
Psychiatric diagnostic evaluation |
5,177 |
4,529 |
$1.76M |
| 90832 |
Psychotherapy, 30 minutes with patient |
14,884 |
10,874 |
$1.16M |
| 90834 |
Psychotherapy, 45 minutes with patient |
10,359 |
6,813 |
$1.12M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
10,886 |
10,209 |
$912K |
| S9485 |
Crisis intervention mental health services, per diem |
789 |
769 |
$893K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
11,152 |
10,438 |
$857K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
4,772 |
4,625 |
$552K |
| 36415 |
Collection of venous blood by venipuncture |
6,824 |
5,911 |
$537K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,206 |
3,098 |
$463K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,889 |
1,680 |
$403K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
2,679 |
2,589 |
$369K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
5,208 |
4,175 |
$317K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
3,140 |
2,835 |
$230K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
4,129 |
3,179 |
$193K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
1,045 |
461 |
$160K |
| 80053 |
Comprehensive metabolic panel |
11,327 |
10,513 |
$150K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
2,868 |
758 |
$141K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
698 |
691 |
$133K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,505 |
2,476 |
$97K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,771 |
1,704 |
$88K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,840 |
1,550 |
$87K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
550 |
537 |
$81K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
2,020 |
2,020 |
$78K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,499 |
2,470 |
$75K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,043 |
1,009 |
$72K |
| 84443 |
Thyroid stimulating hormone (TSH) |
6,500 |
6,440 |
$69K |
| 80061 |
Lipid panel |
5,052 |
5,034 |
$67K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
2,619 |
2,442 |
$64K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
461 |
458 |
$63K |
| 99222 |
Initial hospital care, per day, moderate complexity |
576 |
568 |
$55K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
78 |
78 |
$51K |
| H2011 |
Crisis intervention service, per 15 minutes |
789 |
621 |
$50K |
| 87631 |
|
516 |
510 |
$41K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
513 |
509 |
$41K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,113 |
2,874 |
$41K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
712 |
703 |
$40K |
| 87480 |
|
1,950 |
1,917 |
$39K |
| 87660 |
|
1,939 |
1,907 |
$39K |
| 87510 |
|
1,909 |
1,878 |
$39K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
1,056 |
612 |
$35K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
668 |
658 |
$35K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
578 |
250 |
$33K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
7,421 |
6,973 |
$31K |
| 84439 |
|
2,282 |
2,258 |
$29K |
| G0396 |
Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes |
285 |
149 |
$28K |
| 99401 |
|
607 |
547 |
$25K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
334 |
323 |
$25K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,851 |
2,844 |
$24K |
| 82607 |
|
1,916 |
1,911 |
$24K |
| 99402 |
|
403 |
400 |
$20K |
| 82043 |
|
1,299 |
1,297 |
$20K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
567 |
417 |
$20K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
1,185 |
1,180 |
$19K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
24 |
24 |
$17K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,291 |
2,220 |
$16K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
299 |
282 |
$14K |
| 70450 |
Computed tomography, head or brain; without contrast material |
52 |
52 |
$14K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
64 |
52 |
$14K |
| D0150 |
Comprehensive oral evaluation - new or established patient |
244 |
80 |
$13K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
60 |
38 |
$13K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
26 |
25 |
$12K |
| 86780 |
|
1,066 |
1,052 |
$11K |
| 86803 |
|
747 |
745 |
$11K |
| 82728 |
|
733 |
723 |
$10K |
| 85027 |
|
2,770 |
2,690 |
$9K |
| 82570 |
|
1,564 |
1,531 |
$9K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
12 |
12 |
$9K |
| 84702 |
|
686 |
566 |
$8K |
| 99233 |
Prolong inpt eval add15 m |
131 |
55 |
$8K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
39 |
39 |
$8K |
| 83735 |
|
1,025 |
995 |
$8K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
94 |
93 |
$8K |
| 81025 |
|
1,016 |
1,004 |
$8K |
| 87340 |
|
678 |
675 |
$8K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
714 |
705 |
$8K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
90 |
90 |
$6K |
| H0005 |
Alcohol and/or drug services; group counseling by a clinician |
111 |
38 |
$6K |
| 87634 |
|
125 |
125 |
$5K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
962 |
932 |
$5K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
73 |
73 |
$5K |
| 99152 |
|
531 |
522 |
$5K |
| 87081 |
|
857 |
854 |
$5K |
| 80050 |
General health panel |
319 |
314 |
$5K |
| 83550 |
|
413 |
407 |
$5K |
| 85610 |
|
957 |
824 |
$4K |
| D1110 |
Prophylaxis - adult |
88 |
73 |
$4K |
| 81001 |
|
1,520 |
1,494 |
$4K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
66 |
40 |
$4K |
| 83880 |
|
125 |
107 |
$4K |
| G0500 |
Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) |
240 |
161 |
$4K |
| 82746 |
|
250 |
250 |
$3K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
13 |
13 |
$3K |
| 86850 |
|
285 |
285 |
$3K |
| 80076 |
|
405 |
395 |
$3K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
69 |
56 |
$3K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
27 |
27 |
$3K |
| 83540 |
|
519 |
511 |
$3K |
| 43235 |
|
34 |
26 |
$3K |
| H2010 |
Comprehensive medication services, per 15 minutes |
39 |
38 |
$3K |
| 87077 |
|
220 |
208 |
$3K |
| 86140 |
|
564 |
545 |
$3K |
| 97161 |
|
24 |
24 |
$2K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
12 |
12 |
$2K |
| 87186 |
|
289 |
279 |
$2K |
| G0397 |
Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and intervention, greater than 30 minutes |
19 |
12 |
$2K |
| 99442 |
|
38 |
38 |
$2K |
| 86706 |
|
171 |
170 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
18 |
18 |
$2K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
292 |
289 |
$2K |
| D2391 |
Resin-based composite - one surface, posterior, primary or permanent |
35 |
27 |
$2K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
14 |
14 |
$2K |
| 85652 |
|
703 |
680 |
$2K |
| D0120 |
Periodic oral evaluation - established patient |
51 |
30 |
$2K |
| 86900 |
|
317 |
314 |
$1K |
| 86901 |
|
316 |
313 |
$1K |
| 87070 |
|
148 |
145 |
$1K |
| 71046 |
Radiologic examination, chest; 2 views |
85 |
84 |
$1K |
| D2392 |
Resin-based composite - two surfaces, posterior, primary or permanent |
13 |
12 |
$1K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
89 |
89 |
$999.71 |
| D0274 |
Bitewings - four radiographic images |
23 |
18 |
$915.40 |
| 81003 |
|
446 |
440 |
$858.55 |
| 99051 |
|
60 |
51 |
$748.27 |
| 59025 |
Fetal non-stress test |
31 |
27 |
$733.25 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
32 |
31 |
$640.00 |
| 86038 |
|
51 |
51 |
$636.62 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
36 |
36 |
$630.60 |
| 84480 |
|
39 |
37 |
$574.87 |
| 83520 |
|
40 |
40 |
$547.96 |
| 99441 |
|
25 |
25 |
$509.87 |
| 86762 |
|
66 |
66 |
$468.14 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
12 |
12 |
$464.04 |
| 86704 |
|
30 |
30 |
$421.36 |
| 84403 |
|
12 |
12 |
$366.17 |
| 84703 |
|
42 |
42 |
$356.24 |
| D0140 |
Limited oral evaluation - problem focused |
13 |
13 |
$315.57 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
17 |
17 |
$301.14 |
| 90686 |
|
12 |
12 |
$219.71 |
| 83001 |
|
14 |
14 |
$203.42 |
| 84146 |
|
12 |
12 |
$199.21 |
| 83655 |
|
13 |
13 |
$183.04 |
| 87088 |
|
13 |
13 |
$141.73 |
| 83690 |
|
26 |
26 |
$124.92 |
| Q9963 |
High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml |
26 |
26 |
$121.09 |
| 82550 |
|
13 |
13 |
$77.52 |
| 96127 |
|
20 |
20 |
$72.40 |
| 82248 |
|
13 |
13 |
$47.62 |